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Background: Cryopreservation of ovarian tissue has been suggested as an alternative to restore fertility for ovarian
failure before chemotherapy.
Methods: Ovaries of donor FVB/N-Tg (PolII–Luc) Ltc transgenic mice (n = 5) were cryopreserved and transplanted to
the back muscles of recipient FVB/NJNarl wild-type mice that had undergone bilateral oophorectomy. We evaluated
the fate of cryopreserved murine ovarian grafts by in vivo bioluminescent imaging (BLI), AMH mRNA expression and
follicle counts.
Results: There were significantly stronger BLI signals in the fresh ovaries than in the frozen–thawed ones. The number
of primordial follicles was significantly lower in frozen–thawed ovaries at 10 days after transplantation (P < 0.001). The
AMH mRNA expression was significantly lower in the frozen–thawed ovaries (P < 0.001), showing that unavoidable
harm occurs after transplantation.
Conclusions: Ovarian cryopreservation by slow freezing compromises ovarian reserve by cryoinjury and ischemia,
evident at an early stage after transplantation.
Keywords: AMH, Bioluminescence imaging, Cryopreservation, Ovary, TransgenicBackground
Cryopreservation of ovarian tissue has been conducted
since the 1990s and has been suggested as an alternative
to restore fertility for girls and women who are at high
risk for ovarian failure after chemotherapy or radiother-
apy [1-3]. This technique has several advantages over
the simple cryopreservation of oocytes and embryos.
First, in theory, it should preserve a large number of im-
mature oocytes within primordial follicles, independent
of the menstrual cycle, and does not delay cancer ther-
apy. Second, cryopreservation of ovarian tissue can pre-
serve the endocrine functions of the ovary, which cannot
be achieved by cryopreserving the oocyte or embryo. In
addition, this strategy is also suitable for prepubertal
girls [4,5]. Cryopreservation of ovarian tissues has gener-
ally been performed using slow freezing methods using a
programmed freezer [6,7]. However, cryopreservation of* Correspondence: tzengcr@tmu.edu.tw
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unless otherwise stated.ovarian tissue is complicated, as it is comprises several
different cell types that have different requirements for
survival.
Primordial follicles have been reported to have toler-
ance to cryopreservation because of their relative abun-
dance (90% of the ovary by mass), relatively inactive
metabolic rate, small size and absence of the zona pellu-
cida and peripheral cortical granules [8-10]. However,
the effect of cryopreservation of ovarian tissue on the
development of primordial follicles remains to be eluci-
dated. Anti-Müllerian hormone (AMH) is expressed in
granulosa cells and is considered to be the best hormo-
nal marker for the ovarian follicular reserve. Thus, a
measure of AMH can be applied to the clinical evalu-
ation of follicular reserves and function [11-14].
With the advent of in vivo bioluminescent imaging
(BLI), luciferase reporter genes have been used widely in
various biomedical fields for the noninvasive investiga-
tion of cellular and molecular events involved in normal
and pathological processes [15]. In this study, our ob-
jective is to evaluate the fate of cryopreserved murine
ovarian grafts by using in vivo BLI in real time, based ontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tively in the short term, and by measuring the expression
of AMH mRNA using real-time quantitative polymerase
chain reaction (qPCR) amplification and follicle counts
as the evidence whether the ovarian cryopreservation by
slow freezing method was compromised the ovarian
reserve at an early stage after transplantation.
Methods
Mice
Five-week-old FVB/N-Tg (PolII-luc) Ltc transgenic fe-
male mice with an H-2 haplotype (H2
q) were used as
ovarian tissue donors. The gene fragment construct
polII-luc encodes a 712-bp mouse RNA polymerase (Pol)
II promoter and a modified firefly luciferase cDNA. This
transgenic line was created using microinjection of the
polII-Luc transgene into fertilized FVB/N embryo pro-
nuclei and maintained as a hemizygotic stock (Level
Transgenic Center of Level Biotechnology Inc. Taipei,
Taiwan). Age-matched inbred FVB/NJNarl wild-type mice
(National Laboratory Animal Center, Taipei, Taiwan) were
used as recipients (n = 5). All mice were housed under
a 12 h light: 12 h dark regimen at 22–24°C, with food
and water ad libitum. All procedures were reviewed and
approved by the Animal Experimental Committee at the
National Defense Medical Center and Tri-Service General
Hospital, Taipei, Taiwan, in accordance with the Guiding
Principles for the Care and Use of Laboratory Animals.
Study design
The mice were treated intraperitoneally (i.p.) with keta-
mine (50 mg/kg) and xylazine (15 mg/kg) to induce
general anesthesia. Recipient mice underwent bilateral
ovariectomy 1 week before transplantation. Transgenic
fresh or frozen–thawed ovarian tissues were transplanted
under the back muscle of the donor animals (Figure 1).
Recovery was uneventful, and during the postoperative
period no signs of discomfort or infection were noticed.
At 10 days after transplantation, the animals were eutha-
nized, and ovarian tissues were assayed by BLI, by real-
time qPCR for AMH mRNA levels, and by histology of
follicle numbers and morphology.
Slow freezing
Ovaries taken from the donor mice after euthanasia
were either transplanted fresh (controls) or cryopre-
served slowly using a modification of the method of
Gosden et al. [16]. For cryopreservation, the ovaries
were suspended in a cryoprotectant medium of human
tubal fluid (HTF) medium supplemented with 10% fetal
bovine serum (FBS) and 1.5 M mol/L dimethylsulfoxide
(DMSO, Sigma-Aldrich, St Louis, MO, USA) on crushed
ice. Each ovary was then drawn up into the middle of a
0.25 mL plastic freezing straw with a small volume ofcryoprotectant medium. The straws were sealed with
polyvinyl chloride powder and held on ice for 30 min be-
fore they were placed in a planer programmable freezer
precooled to 0°C. The straws were cooled at −2°C/min
to −7°C and held for 5 min, seeded manually, held at −7°C
for a further 10 min, cooled to −40°C at −0.3°C/min, fur-
ther cooled to −140°C at −10°C/min and finally transferred
to liquid nitrogen for storage. For thawing of the ovaries,
the straws were removed from liquid nitrogen, held in
air for 20 s and transferred to a water bath at room
temperature for 10–20 s. The contents of the straws were
emptied into HTF medium with 10% FBS. The DMSO
was removed by repeated rinsing. Ovaries were kept in
this medium at room temperature for 10 min before being
used for transplantation.
Bioluminescence imaging of transplanted ovaries
The Xenogen IVIS-50 imaging system (Xenogen,
Hopkinton, MA, USA) was used for BLI. Mice were
injected with 150 mg luciferin/kg (i.p.) 5 min before
imaging. The luciferin solution was sterilized by passing it
through a 0.22 μm filter. Mice were placed in the imaging
chamber under continuous isoflurane (2%) anesthesia. The
animals were rotated to the left to expose the flank opti-
mally to the camera.
Histology and follicle counting
Fixed fresh and frozen–thawed ovarian grafts were em-
bedded in paraffin wax and serially sectioned at 6 μm,
and the sections were stained with hematoxylin and eosin
(HE) after dewaxing. Sections for analysis were taken at
36 μm intervals, and only follicles containing an oocyte
were counted to avoid counting follicles twice. Healthy,
nonatretic follicles were classified as primordial, primary,
secondary, or antral. Primordial follicles had one layer of
flattened granulosa cells surrounding the oocyte; primary
follicles had a single layer to multiple layers of cuboidal
granulosa cells without theca cells; secondary follicles had
multiple layers of cuboidal granulosa cells, presence of
theca cells and larger size than primary follicles; and antral
follicles had a fluid-filled cavity adjacent to the oocyte.
Reverse transcription (rt) and real-time qpcr
Single-strand cDNA was reverse transcribed from total
RNA (2 μg) using a High Capacity cDNA Reverse Tran-
scription kit (Applied Biosystems Pty Ltd.; Life Tech-
nologies Ltd., Paisley UK) and random primers. The RT
conditions consisted of 10 min of annealing at 25°C,
120 min of cDNA synthesis at 37°C and 5 min of inacti-
vation at 85°C.
Genes for AMH and glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) were quantified by real-time qPCR
with a StepOne thermal cycler (Applied Biosystems) using
a commercial kit (Power SYBR Green PCR Master Mix;
Figure 1 Scheme of the study design.
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Primer-3 (http://primer3.ut.ee/) based on sequences in
the GenBank database (http://www.ncbi.nlm.nih.gov). The
amplification program consisted of an initial 10 min activa-
tion at 95°C followed by 40 cycles of PCR (each cycle con-
sisting of 15 s of denaturation at 95°C and 60 s of annealing
at 60°C). The amount of template cDNA used in each reac-
tion was normalized to the amount of GAPDH mRNA.
Amplification of template cDNA was in the linear range
for the number of PCR cycles, and RT–PCR of GAPDH
transcripts was performed using the same amount of
cDNA from each sample as a template. The mRNA levels
were normalized to those of GAPDH mRNA and were
expressed as a percentage of the mRNA levels of fresh
ovaries transplanted for 1 day, which was taken as 100%.
Oligonucleotide PCR primers were selected with the assist-
ance of a computer program (Primer-3) designed to
optimize GC contents and melting temperature, and to
minimize hairpin and dimer formation. The selected PCR








All data including follicle counts and the relative mRNA
levels of molecular marker expression are expressed as
the mean ± SD and were analyzed by univariate ana-
lysis of variance (ANOVA). All analyses were conducted
using the statistical software package R version 2.6.2
(R Foundation for Statistical Computing, Vienna, Austria),
and P < 0.05 was considered statistically significant.
Results and discussion
There were significantly stronger BLI signals in the
transplanted fresh control ovaries than in the frozen–
thawed ovaries. In the fresh ovaries, bioluminescence
increased initially on day 3, decreased between days 3
and 7 and rose again from day 7 to day 10 with a subse-
quent cyclic fluctuation in intensity. However, there
was measurable BLI output and cyclic fluctuation up to
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(Figure 2).
In order to determine the effect of cryopreservation of
ovarian tissues, the number of primordial, primary, sec-
ondary and antral follicles was counted in ovarian grafts
10 days after transplantation (Figure 3). The total num-
bers of follicles in frozen–thawed ovaries were significantly
decreased compared with fresh controls (P < 0.001). In
addition, we evaluated the level of AMH mRNA in fresh
and cryopreserved ovaries after transplantation (Figure 4).
The AMH mRNA expression in both groups declined on
day 3 after transplantation. The level of AMH was signifi-
cantly higher in the fresh ovaries than those frozen–thawed
(P < 0.001), showing that the latter ovaries had suffered un-
avoidable harm after transplantation.
The number of primordial follicles was significantly
lower in frozen–thawed ovaries compared with fresh
controls at 10 days after transplantation. The mRNA ex-
pression of AMH was also significantly higher in fresh
ovarian grafts than in the frozen–thawed ones. The re-
duced mRNA level and primordial follicle counts in the
transplanted frozen–thawed ovaries can be attributed to
cryoinjury and subsequent ischemia after transplantation.Figure 2 Ovaries of a transgenic FVB/N-Tg (PolII–Luc) Ltc mouse were
recipient mouse (left). In vivo BLI of mouse ovarian grafts in fresh and fro
transplantation (upper right). In the fresh ovaries, bioluminescence increase
again from day 7 to day 10 with a subsequent cyclic fluctuation in intensit
after transplantation (lower right).In general, the aim of cryopreservation of ovarian tissue is
to isolate the ovarian cortex from the medulla to reduce
the thickness of the transplant, thereby optimizing follicu-
lar survival [17].
The major challenges for ovarian cryopreservation in-
clude defining an optimal protocol for cryopreserving
large tissue masses, development of nontoxic cryopro-
tectants and prevention of ischemia–reperfusion tissue
damage. The follicular survival rate obtained with frozen–
thawed human ovarian tissue is approximately 70%–80%
[7,17]. Choi et al. [18] evaluated the effect of cryopreserva-
tion (slow freezing and vitrification) on the development
of frozen–thawed mouse primordial follicles. A significant
reduction was noted in the developmental rate after
in vitro culture of primordial follicles derived from both
types of freezing methods, with a slight reduction com-
pared with controls after 5 days of culture. Earlier studies
revealed that almost 50% of primordial follicles are lost be-
cause of initial ischemia rather than during the freeze–
thaw process itself [19-21].
Although primordial follicles might be resistant to
freezing–thawing [7,17], the damage may be contrib-
uted by subsequent transplantation without vasculartransplanted under the back muscle (arrow) of FVB/N wild-type
zen–thawed ovary transplant groups on days 1, 3, 5, 7 and 10 after
d initially on day 3, then decreased between days 3 and 7 and rose
y. In the frozen–thawed ovaries, the bioluminescence was no different
Figure 3 Follicles were classified as primordial, primary, secondary, or antral (arrow). Primordial follicles had one layer of flattened granulosa
cells surrounding the oocyte; primary follicles had a single layer to multiple layers of cuboidal granulosa cells without theca cells; secondary follicles
had multiple layers of cuboidal granulosa cells, presence of theca cells and larger size than primary follicles; and antral follicles had a fluid-filled
cavity adjacent to the oocyte. Bar = 50 μm (Left). Estimated primordial, primary, secondary and antral follicle counts of fresh and frozen–thawed
ovaries on day 10 after transplantation. The total numbers of follicles in frozen–thawed ovaries were significantly decreased compared with the
transplanted fresh controls. Data are expressed as the mean ± standard deviation. ***P < 0.001(Right).
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tomosis remains a problem for implants because the
process of revascularization takes 2–7 days to complete,
depending on the size of the implant [16,23]. Donnez
et al. [24] stated that the transplantation of ovarian tissue
pieces without a vascular pedicle requires the establish-
ment of a new blood supply that takes 5 days. This leads
to a substantial loss of follicles because of hypoxia and is-
chemia of the graft. Van Eyck et al. [25,26] found that hu-
man ovarian xenografts were exposed to hypoxia before
day 5 and were progressively revascularized by day 10.
In order to evaluate these short- and long-term tissue
variations, BLI may be used as a convenient noninvasiveFigure 4 The AMH mRNA expression in fresh and frozen–thawed
transplanted ovaries over time (days 1, 3, 5, 7 and 10). The mRNA
expression in fresh and frozen–thawed ovaries increased on day 3 after
transplantation and declined gradually thereafter. Data are expressed as
the mean ± standard deviation. ***P< 0.001.technique for following early or late whole tissue changes
in vivo.
Bioluminescence imaging is a nondestructive technique
capable of repeated measurements [27]. Its advantages
include sensitivity, efficiency, relatively low cost and ver-
satility. Most imaging systems provide 2-dimensional
(2D) information in small animal models, showing the lo-
cations and intensity of light emitted from the animal in
pseudocolor scaling. A 3-dimensional (3D) capability for
BLI is now available but is more expensive and less effi-
cient. This technique is now being used to detect the lo-
cation and burden of xenografted tumors, or to identify
and measure the number of immune or stem cells after
adoptive transfer. Specialized applications of BLI also fol-
low tissue-specific luciferase expression in transgenic
mice and monitoring of biological processes such as sig-
naling or protein interactions in real time [15]. Here, the
application of 2D BLI was the first attempt to investigate
cryopreserved ovarian grafts in vivo over time. It has
shown that we could use BLI to explore optimal proto-
cols for ovarian cryopreservation.
In our previous studies, we applied BLI as a tool to
evaluate the effects of immunosuppression after allo-
transplantation of ovarian grafts [28], to track the rejec-
tion and survival of mouse ovarian iso- and allografts,
and to evaluate germ cells in vitro and transplantation
in vivo as a part of fertility preservation in prepubertal
male mice [29,30].
Folliculogenesis in ovarian grafts has been evaluated
by molecular biology and histology. An ovary-specific
gene such as that for growth differentiation factor-9
(GDF-9) might serve as a landmark for studying follicu-
logenesis. In our study, the Pol II promoter was used to
evaluate the tissue in situ using BLI. Most such imaging
systems provide 2D information, showing the locations
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color scaling. In this, the algorithm tries to reconstruct
what is happening inside the mouse by providing an ap-
proximate 3D reconstruction. Then, a digital mouse atlas
is overlaid onto the 3D diffuse tomography reconstruc-
tion to obtain anatomical reference points. The Caliper
algorithm for 3D reconstruction takes longer because it
is based on the assumption that the mouse is optically
homogeneous. Hence, 3D diffuse tomography reconstruc-
tion seems to perform well for a parenchymal organs like
the liver.
The drawback of our study is that the Pol II promoter
may only be able to quantify viable tissue of the ovarian
graft, and not each stage of folliculogenesis individually.
Therefore, it will be essential to design ovary-specific
promoters for following the fate of each stage of follicu-
logenesis after protocols using cryopreservation and dif-
ferent transplantation sites. In brief, we have paved the
way to demonstrating a model of in vivo imaging by BLI
for ovarian graft transformation and survival. The im-
pact of these interventions on folliculogenesis needs to
be evaluated by versatile study designs.
Conclusions
Our study suggests that ovarian cryopreservation using
slow freezing compromised the ovarian reserve at an early
stage after transplantation. This was caused by cryoinjury
and ischemia leading to follicle loss. This study also dem-
onstrates the promise of luciferase gene-based systems,
which are widely used in the field of genetic engineering as
reporters. Analysis by in vivo BLI has also been harnessed
for reproductive biomedical research and minimizes bio-
logical variation. A noninvasive in vivo approach does not
require sacrificing the experimental animal and thereby re-
duces the numbers required for experimentation because
multiple measurements can be made in the same animal
over time.
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